Previous 10 | Next 10 |
Mesoblast Tenders Completed Biologics License Application Mesoblast Limited ( MESO ) announced that it has filed a completed Biologics License Application ((BLA)) with the United States Food and Drug Administration for its lead allogeneic cell therapy Ryoncil. The therapy is aimed at tre...
Image source: The Motley Fool. Waters Corporation (NYSE: WAT) Q4 2019 Earnings Call Feb 4, 2020 , 8:00 a.m. ET Operator Continue reading
Waters Corporation (WAT) Q4 2019 Results Earnings Conference Call February 04, 2020, 08:00 AM ET Company Participants Bryan Brokmeier - Senior Director, IR Christopher O'Connell - Chairman and CEO Sherry Buck - SVP and CFO Conference Call Participants Vijay Kumar - Evercore...
Schmitt Industries (NASDAQ: SMIT ) -20% as it intends to delist and deregister common stock from the Nasdaq. More news on: Schmitt Industries, Inc., Rockwell Medical, Inc., Micro Focus International plc, Stocks on the move, , Read more ...
Waters (NYSE: WAT ) Q4 results : More news on: Waters Corporation, Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Tech stocks news, Read more ...
Waters (NYSE: WAT ): Q4 Non-GAAP EPS of $3.20 beats by $0.19 ; GAAP EPS of $3.12 beats by $0.17 . Revenue of $716.3M (+0.2% Y/Y) beats by $1.96M . Press Release More news on: Waters Corporation, Earnings news and commentary, Tech stocks news,
Fourth Quarter 2019 Highlights Sales of $716 million were flat as reported and grew 1% in constant currency Strong recurring revenue, partially offset by a decline in instrument sales Growth in Europe and India, somewhat offset by softness in other geographies GAA...
Waters (NYSE: WAT ) is scheduled to announce Q4 earnings results on Tuesday, February 4th, before market open. The consensus EPS Estimate is $3.01 (+4.9% Y/Y) and the consensus Revenue Estimate is $714.34M (-0.1% Y/Y). Over the last 2 years, WAT has beaten EPS estimates 88% of t...
The following slide deck was published by Waters Corporation in conjunction with this Read more ...
Waters enables core product portfolio with next-generation automation technology Waters Corporation (NYSE:WAT) announced today that it has entered into a definitive agreement to acquire Andrew Alliance, an innovator in specialty laboratory automation technology, including software and ...
News, Short Squeeze, Breakout and More Instantly...
Waters Corporation (NYSE: WAT) Reports Second Quarter 2024 Financial Results PR Newswire Highlights Sales of $709 million exceeded guidance on a reported basis, declined 4% as reported and 4% in organic constant currency GAAP EPS of $2.40 ; earnin...
Waters New Rapid Screening-DSC Enables Up to 24x Faster Thermal Stability Testing at Ultra-Low Sample Volumes for Antibody Drugs PR Newswire News Summary: Reduces sample volume requirements by 25x through use of advanced microfluidic technologies while increasing throu...
Waters Corporation Schedules Second Quarter 2024 Earnings Conference Call PR Newswire MILFORD, Mass. , July 2, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q2 2024 financial results conference call live on Wednesday, July 31st, 2024 at 8...